Related Experiment Video
Updated: Apr 20, 2026
Implantation of an Isoproterenol Mini-Pump to Induce Heart Failure in Mice
Published on: October 3, 2019
Is AMPK the savior of the failing heart?
1Cardiovascular Research Centre, Mazankowski Alberta Heart Institute, Department of Pediatrics, Faculty of Medicine and Dentistry, 458 Heritage Medical Research Centre, University of Alberta, Edmonton, AB, T6G 2S2, Canada.
Insights
Heart failure (HF) involves metabolic defects impacting ATP production. AMP-activated protein kinase (AMPK) plays a crucial role in regulating myocardial metabolism during HF progression.
Area of Science:
- Cardiology
- Molecular Biology
- Biochemistry
Background:
- Heart failure (HF) is a major global health issue, responsible for millions of deaths.
- Pathophysiological and molecular changes significantly contribute to HF development and progression.
- Defects in myocardial energy metabolism, crucial for ATP production and contractile function, are implicated in HF pathogenesis.
Purpose of the Study:
- To review metabolic alterations in HF.
- To examine the role of energy metabolism changes in HF progression.
- To explore the involvement of AMP-activated protein kinase (AMPK) in HF metabolism.
Main Methods:
- Literature review of studies on HF metabolism.
- Analysis of the role of energy metabolism in HF.
- Focus on AMP-activated protein kinase (AMPK) pathways.
Main Results:
- Myocardial metabolic dysfunction is a key factor in HF.
- Altered energy metabolism contributes to the worsening of HF.
- AMPK is a central regulator of myocardial metabolism in the context of HF.
Conclusions:
- Metabolic changes are critical in HF.
- AMPK is a significant target for understanding and potentially treating HF.
- Further research into metabolic pathways in HF is warranted.
Abstract:
Heart failure (HF) is one of the leading causes of death, affecting more than 20 million people worldwide. A vast array of pathophysiological and molecular events contributes to the development and eventual worsening of HF. Of these, defects in myocardial metabolic processes that normally result in proper ATP production necessary to maintain contractile function appear to be a major contributor to HF pathogenesis. A key player involved in regulating myocardial metabolism is AMP-activated protein kinase (AMPK), a major regulatory kinase controlling numerous metabolic pathways. Here, we review the metabolic changes that occur in HF, what role alterations in energy metabolism has in its progression, and the involvement of AMPK in this context.
Related Concept Videos
01:27Heart Failure I: Introduction
01:17Pathophysiology of Heart Failure
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
01:29Heart Failure II: Pathophysiology
01:22Heart Failure Drugs: β-Blockers
01:30Heart Failure V: Medical Management